Press Releases
Bexion Pharmaceuticals, Inc. Presents Clinical Data at 2018 SNO Annual Meeting
FOR IMMEDIATE RELEASE Covington, KY ~ 19 November 2018 Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on rare brain and solid tumors, announced today that a clinical oral report followed by poster review and a second case study poster were presented at the Society of Neuro-Oncology (SNO) Annual Meeting held November 16-18 in New Orleans, LA. The SNO Annual Meeting brings together [...]
Bexion Pharmaceuticals, Inc. Represented at 15th Annual BioNetwork Partnering Summit
National Cancer Institute (NCI) Selects Bexion as a Presenting Company FOR IMMEDIATE RELEASE [Covington, KY ~ October 18, 2018] Bexion Pharmaceuticals, Inc., a clinical stage biotechnology company focused on developing innovative cures for cancer, announces that Dr. Ray Takigiku, Founder and CEO of the Company presented recently at the 15th Annual BioNetwork Partnering Summit, held in Laguna Nigel, CA from October 10-12, 2018. [...]
Bexion Pharmaceuticals, Inc. Announces Grant from CancerFree KIDS
CancerFree KIDS Awards Nationwide Children’s Hospital Monies to Initiate Pediatric Trial FOR IMMEDIATE RELEASE Covington, KY, June 19, 2018 Sometimes things come full circle. Fourteen years ago, CancerFree KIDS awarded its very first research grant to a young investigator at Cincinnati Children’s Hospital Medical Center (CCHMC) to study a long shot idea that no one else would fund. This year CancerFree KIDS announced [...]
Bexion Pharmaceuticals, Inc. Announces Data at 2018 ASCO Annual Meeting from Ongoing Phase I BXQ-350 Clinical Trial
FOR IMMEDIATE RELEASE Covington, KY ~ June 12, 2018 Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on rare brain and solid tumors, discussed data from 17 patients enrolled in the Phase Ia portion of its ongoing Phase I Safety Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting Poster Session, held in Chicago June 1-5, 2018. In the poster presentation [...]
Bexion Pharmaceuticals, Inc. To Present Clinical Data at 2018 ASCO Annual Meeting
FOR IMMEDIATE RELEASE Covington, KY ~ May 22,2018 Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on rare brain and solid tumors, announced today that it will feature one clinical poster presentation and three online publications at the American Society of Clinical Oncology (ASCO) Annual Meeting to be held June 1-5 in Chicago, IL. The ASCO Annual Meeting brings together more than 32,000 [...]
Bexion Pharmaceuticals, Inc. Presentations Accepted at 2018 ASCO Annual Meeting
FOR IMMEDIATE RELEASE Covington, KY April 16, 2018 Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on rare brain tumors, announced today that the four abstracts submitted for presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting held June 1-5, 2018 in Chicago, Illinois have all been accepted. One of the accepted presentations is entitled “First-in-human, First-in-class Phase 1a Study of [...]
